Chesnara (CSN): Scottish Widows Europe acquisition
This situation live
CSN Chesnara
17 Feb 2026 · Agreed; completion expected around end 2026 · −11% until the next step
Completion of the Acquisition expected around end 2026, subject to customary regulatory approvals.
24 Mar 2026 · Agreed; completion expected around end 2026 · +17% until the next step
Expected to complete around the end of 2026.
25 Aug 2026 · Change in Control application submitted; completion around end-2026 · −1% since
The regulatory Change in Control application has been submitted and is expected to complete around the end of 2026.
Scottish Widows Europe acquisition
Change in Control application submitted; completion around end-2026
Next: Regulatory Change in Control approval and completion
Every step · 3
- 17 Feb 2026 Agreed; completion expected around end 2026 – Completion of the Acquisition expected around end 2026, subject to customary regulatory approvals. ↗
- 24 Mar 2026 Agreed; completion expected around end 2026 – Expected to complete around the end of 2026. ↗
- 25 Aug 2026 Change in Control application submitted; completion around end-2026 – The regulatory Change in Control application has been submitted and is expected to complete around the end of 2026. ↗
What is happening
Chesnara: Scottish Widows Europe acquisition – Change in Control application submitted; completion around end-2026. ['Change in Control application submitted; completion around end-2026']
- Announced
- 17 Feb 2026 · Agreed; completion expected around end 2026
- Latest
- 25 Aug 2026 · Change in Control application submitted; completion around end-2026
- Why
- Adds UK scale, with about £5bn of AUA and £140m of cash generation over the first five years, funded by internal resources and a £140m equity raise.
- Value
- £247.0m · 32% of market value – total consideration for the HSBC Life (UK) acquisition, now Chesnara Life
- Seller
- HSBC Life (UK) Limited
- The business
- Loss-making · Total consideration £247m; adds £5bn AUA; £140m cash generation over first five years
- What it changes
- Confirms HSBC Life (UK) integration is on track, with solvency above the pro-forma estimate and the interim dividend raised 6%. The Scottish Widows Europe deal timeline is unchanged, and HY26 OCG is flattered by acquisition effects.
What comes next
Regulatory Change in Control approval and completion.
From the company's own announcements. Not investment advice.
Briefing Pro
New to Chesnara? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the CSN briefing →Also at Chesnara 1 open
Insider conviction1 director buying – £14k in 1 buy
Insider conviction2 directors buying – £71k in 2 buys · closed
Insider conviction6 directors buying – £364k in 6 buys · closed
Insider conviction2 directors buying – £70k in 2 buys · closed
Insider conviction1 director buying – £26k in 1 buy · closed
Chesnara – company page →